In August, the U.S. Food and Drug Administration (FDA) approved ACAM2000, manufactured by Emergent BioSolutions, for use against mpox. Emergent BioSolutions’ shot received approval for smallpox in 2007. According to The Defender, the company “specializes in vaccines for biochemical warfare threats such as anthrax and smallpox.” Since the FDA’s approval, social media users have revealed the catastrophic risks of the shot. “FDA approves Emergent BioSolutions’ ACAM2000 vaccine (live vaccinia virus) for MPOX, which has black box warnings for myopericarditis, encephalitis, and severe vaccinial infections that can result in severe disability and/or death,” McCullough Foundation wrote. “The approval is for prevention of MPOX disease in individuals determined to be at high risk for MPOX infection. The vaccine was first approved by the FDA in 2007 for active immunization for the prevention of smallpox disease in individuals determined to be at high risk for smallpox infection,” it continued. “The decision to approve this vaccine for MPOX prevention is concerning, especially given its known risks. Considering that the alternative MPOX vaccine (JYNNEOS) has a significantly better safety profile and that Tecovirimat has demonstrated effectiveness in treating MPOX, this approval raises serious questions about the prioritization of safety,” it added. JUST IN – FDA approves Emergent BioSolutions’ ACAM2000 vaccine (live vaccinia virus) for MPOX, which has black box warnings for myopericarditis, encephalitis, and severe vaccinial infections that can result in severe disability and/or death. The approval is for prevention of… pic.twitter.com/yWPdSbq9Df — McCullough Foundation (@McCulloughFund) August 31, 2024 * Image from McCullough Foundation X Post * “This is disaster waiting to happen!” one X user commented. ACAM2000 is a vaccine used to prevent smallpox and mpox disease. Read from the FDA site:https://t.co/ZVxvBqVyXq This is disaster waiting to happen! pic.twitter.com/0RlFN2pttZ — Toast on the Side (@toastontheside) September 17, 2024 Karl Jablonowski, Ph.D., senior research scientist at Children’s Health Defense, said the FDA’s approval of the shot is a “public hazard, not the practice of public health,” The Defender noted. “You can call ACAM2000 a ‘vaccine,’ but its impact on the United States will be as a ‘disease,’” Jablonowski said, according to the outlet. Who does this?! FDA pic.twitter.com/8L3i9QWFkw — Dr. Kat Lindley (@KLVeritas) September 17, 2024 “Dr. Meryl Nass, an internist and biological warfare expert, told The Defender that the CDC also acknowledged this same figure — myopericarditis in 5.7 per 1,000 primary ACAM2000 vaccinations — during a June 23, 2022, meeting,” The Defender noted. Nass told the outlet “no one should get the vaccine.” A vaccine approved in August by the FDA for people deemed to be at “high risk” for mpox infection may cause more harm than good, according to the FDA’s own medication guide for the product. “You can call ACAM2000 a ‘vaccine,’ but its impact on the United States will be as a… pic.twitter.com/UNSaBZdU1u — “Sudden And Unexpected” (@toobaffled) September 18, 2024 The Defender reports: ACAM2000 can also cause fetal death when taken during pregnancy, the package insert states. Additionally, the shot contains a “live vaccinia virus” that can be spread to — and possibly cause the death of — people who have close contact with the vaccinated person up to 6 weeks following vaccination, according to the medication guide. The guide — which the FDA requires to be given to patients before they get the ACAM2000 vaccine — says, “ACAM2000 can cause serious complications in vaccinated individuals and in their close contacts to whom the vaccine virus has spread.” Jablonowski said, “The spread of vaccinia virus is an infliction and an assault, as an unsuspecting person cannot possibly consent.” “For good reasons you would not consent to this vaccine,” Jablonowski said, “even if you believed your benefits outweigh your risks, as you become a potential vector of a disease that is damaging to the heart and fatal to both fetus and infant.” “ACAM2000 contains live vaccinia virus (a ‘pox’-type virus) that can be spread to individuals who have close contact with the vaccinated individual. ACAM2000 can cause serious complications in vaccinated individuals and in their close contacts to whom the vaccine virus has spread,” the FDA medication guide for ACAM2000 reads. Read the full medication guide HERE.